Prohibition of Online Selling of FDA Certified COVID-19 Antibody Test Kits
FDA Circular No. 016-20, issued on May 8, 2020, prohibits the online selling of FDA-certified COVID-19 antibody test kits, emphasizing that these kits are intended solely for professional medical use. This directive aligns with Republic Act No. 9711, which aims to ensure the safety and efficacy of medical devices in the Philippines. The FDA has reiterated the importance of regulating these products to protect public health and has tasked its Regional Field Offices with monitoring compliance and enforcing the prohibition. Stakeholders are reminded to adhere strictly to these regulations to avoid penalties.
Law Information
- Reference Number
- FDA Circular No. 016-20
- Date Enacted
- Subcategory
- Food and Drugs Administration of the Philippines
- Jurisdiction
- Philippines
- Enacting Body
- Congress of the Philippines
Full Law Text
May 8, 2020
FDA CIRCULAR NO. 016-20
| TO | : | All Concerned Stakeholders and Parties |
| SUBJECT | : | Prohibition of Online Selling of FDA Certified COVID-19 Antibody Test Kits |
Republic Act No. 9711, otherwise known as the "Food and Drug Administration Act of 2009," and its Implementing Rules and Regulations, declares that it is the policy of the state to ensure the safety, efficacy and quality of IVD medical devices in the country so as to protect the health of the Filipino people.
The FDA issued FDA Advisory No. 2020-497 reiterating the Market Authorization Holder (MAH) of all COVID-19 antibody test kits (rapid test, point-of-care, lateral flow, Elisa, GICA, CLIA among others) with FDA special certification are strictly for medical professional use and not intended for personal use. Furthermore, FDA Advisory No 2020-498 was issued to inform the general public on purchase and administration of all FDA certified COVID-19 antibody test kits. HTcADC
In view of the foregoing, all concerned stakeholders and parties are strongly reminded that online selling of FDA certified COVID-19 antibody test kits is strictly prohibited.
All FDA Regional Field Offices and Regulatory Enforcement Units are directed to conduct exhaustive monitoring of all online platforms to ensure full compliance of this Circular and to pursue and implement immediate regulatory and enforcement actions as warranted.
(SGD.) ROLANDO ENRIQUE D. DOMINGO, MDDirector General
Cite This Law
Prohibition of Online Selling of FDA Certified COVID-19 Antibody Test Kits, FDA Circular No. 016-20, May 8, 2020 (Philippines)
Prohibition of Online Selling of FDA Certified COVID-19 Antibody Test Kits, FDA Circular No. 016-20 (Phil. 2020)
Related Laws
- Public Health Warning against the Purchase and Use of the Uncertified COVID-19 Test Kit "DeepBlue® COVID-19 (SARS-CoV-2) Antibody Test Kit"FDA Advisory No. 1037-20 • Jun 4, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Public Health Warning against the Purchase and Use of the Uncertified COVID-19 Test Kit "Wiz Biotech Diagnostic Kit (Colloidal Gold) for IgG/IgM Antibody to SARS-CoV-2"FDA Advisory No. 1080-20 • Jun 15, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- List of Approved COVID-19 Rapid Antibody Test KitsFDA Advisory No. 483-20 • Mar 30, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Public Health Warning against the Purchase and Use of the Uncertified COVID-19 Test Kit "Testsealabs® One Step Rapid Test-SARS-cov-2 IgG/IgM Test Cassette"FDA Advisory No. 1054-20 • Jun 10, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Varying Specifications and Use of COVID-19 Rapid Antibody Test KitsFDA Advisory No. 671-20 • Apr 18, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Guidance on Use of COVID-19 Rapid Antibody-based Test KitsDOH Department Circular No. 2020-0160 • Mar 31, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
Browse More Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
Explore other laws in the Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances category.
View All Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) IssuancesNeed Help Understanding This Law?
Ask our AI assistant to explain provisions, implications, or related laws.
Ask AI About This Law